Florin Court Capital LLP Makes New Investment in ARK Genomic Revolution ETF $ARKG

Florin Court Capital LLP purchased a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 31,700 shares of the company’s stock, valued at approximately $880,000. ARK Genomic Revolution ETF accounts for 0.7% of Florin Court Capital LLP’s holdings, making the stock its 29th largest position. Florin Court Capital LLP owned about 0.07% of ARK Genomic Revolution ETF at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Truist Financial Corp purchased a new stake in ARK Genomic Revolution ETF during the 3rd quarter valued at about $305,000. Summit Investment Advisory Services LLC bought a new stake in ARK Genomic Revolution ETF in the third quarter valued at approximately $306,000. Wealth Enhancement Advisory Services LLC lifted its position in ARK Genomic Revolution ETF by 4.0% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 17,394 shares of the company’s stock valued at $522,000 after purchasing an additional 668 shares during the last quarter. Stephens Inc. AR purchased a new stake in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $290,000. Finally, SG Americas Securities LLC grew its holdings in shares of ARK Genomic Revolution ETF by 5.8% in the third quarter. SG Americas Securities LLC now owns 33,306 shares of the company’s stock worth $925,000 after purchasing an additional 1,834 shares during the last quarter.

ARK Genomic Revolution ETF Stock Up 37.4%

Shares of BATS ARKG opened at $32.43 on Wednesday. The firm’s fifty day moving average is $30.62 and its 200 day moving average is $28.33. ARK Genomic Revolution ETF has a 52 week low of $17.51 and a 52 week high of $31.16.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.